{"id":6062,"date":"2025-01-30T14:32:51","date_gmt":"2025-01-30T13:32:51","guid":{"rendered":"https:\/\/www.ehc.eu\/uncategorized-hr\/ehc-objavljuje-prvo-izdanje-novel-treatment-review-2025-godine\/"},"modified":"2026-04-02T16:31:17","modified_gmt":"2026-04-02T14:31:17","slug":"ehc-objavljuje-prvo-izdanje-novel-treatment-review-2025-godine","status":"publish","type":"post","link":"https:\/\/www.ehc.eu\/hr\/uncategorized-hr\/ehc-objavljuje-prvo-izdanje-novel-treatment-review-2025-godine\/","title":{"rendered":"EHC objavljuje prvo izdanje Novel Treatment Review 2025. godine"},"content":{"rendered":"<!-- hero -->\t<section   class=\"subpage-hero bg-white\">\n\t\t<div class=\"container\">\n\t\t\t<div class=\"relative z-10\">\n\t\t\t\t<div class=\"pt-16 lg:pt-24 pb-24 lg:pb-32\">\n\t\t\t\t\t<div class=\"row justify-between gap-10 lg:gap-0 mt-10 text-center lg:text-left\">\n\t\t\t\t\t\t<div class=\"w-full lg:w-6\/12 lg:self-center\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"title h2\" data-scroll data-fade-up>\n\t\t\t\t\t\t\t\t\t<p class=\"text-[115%]\">EHC objavljuje prvo izdanje Novel Treatment Review 2025. godine<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<figure class=\"absolute size-[41.8rem] lg:size-[82.8rem] bottom-[-10%] right-[-10rem] lg:right-[-5%] image-contain opacity-100 skip-lazy\" data-parallax>\n\t\t\t\t\t<img decoding=\"async\" loading=\"eager\" src=\"https:\/\/etngbd86n6b.exactdn.com\/wp-content\/themes\/cbd\/img\/content-logo-colorfull-2.svg\" alt=\"content-logo-colorfull\">\n\t\t\t\t<\/figure>\n\t\t\t\t\t\t<\/section>\n<!-- overview -->\t<section   class=\"s-overlay-img s-padding bg-red\">\n\t\t<div class=\"container\">\n\t\t\t<div class=\"row w-full lg:flex-row justify-between text-center lg:text-left gap-14 lg:gap-0 relative z-10\">\n\t\t\t\t\t\t\t\t<div class=\"w-full lg:py-10\">\n\t\t\t\t\t<div class=\"bg-white min-h-full py-12 px-10 lg:py-24 lg:pl-24 xl:pl-44 relative radius-20 z-10\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"content mt-8\" data-scroll data-fade-up>\n\t\t\t\t\t\t\t\t<p>EHC je objavio prvo izdanje za 2025. godinu svog <a href=\"https:\/\/academy.ehc.eu\/novel-treatment-product-reviews\/\" target=\"_blank\" rel=\"noopener\"><strong>Novel Treatment Review (NTR),<\/strong><\/a> periodi\u010dnog pregleda novih tretmana hemofilije, von Willebrandove bolesti i drugih rijetkih poreme\u0107aja krvarenja.<\/p>\n<p>Svrha NTR-a je pru\u017eiti a\u017eurirane informacije \u0161iroj zajednici, osobito nacionalnim \u010dlanicama EHC-a (NMO), te op\u0107i pregled brzo mijenjaju\u0107eg krajolika razvoja koagulacijskih proizvoda kod rijetkih poreme\u0107aja zgru\u0161avanja.<\/p>\n<p>Glavni istaknuti dijelovi ovog najnovijeg izdanja uklju\u010duju:<\/p>\n<ul>\n<li>Concizumab (trgova\u010dki naziv Alhemo), inhibitor puteva protiv tkivnih faktora (TFPI), dobio je odobrenje EU za stavljanje u promet.<\/li>\n<li>Europska komisija odobrila je stavljanje u promet marstacimaba (trgova\u010dki naziv Hympavzi), namijenjenog za profilaksu epizoda krvarenja kod pacijenata starijih od 12 godina, te\u017eine najmanje 35 kg, koji imaju te\u0161ku hemofiliju A ili B.<\/li>\n<li>Sangamo Therapeutics ponovno dobiva prava na razvoj i komercijalizaciju giroktokogena fitelparvoveca, kandidata za istra\u017eiva\u010dku gensku terapiju namijenjenog lije\u010denju odraslih s umjereno te\u0161kom do te\u0161kom hemofilijom A, nakon odluke Pfizera o raskidu globalnog ugovora o suradnji i licenci izme\u0111u strana.<\/li>\n<li>Spark Therapeutics \/ Roche objavili su prestanak uzimanja dirloktokogena samoparvovec (SPK 8011, virusni vektor povezan s adeno-domenom s B-domenom izbrisanim ljudskim FVIII genom) kod odraslih s te\u0161kom ili umjereno te\u0161kom hemofilijom A.<\/li>\n<\/ul>\n<p>EHC \u017eeli izraziti zahvalnost <a href=\"https:\/\/www.ehc.eu\/governance\/novel-treatment-review-ntr-committee\/\" target=\"_blank\" rel=\"noopener\"><strong>EHC NTR Radnoj skupini<\/strong><\/a> za njihov doprinos razvoju ovog pitanja.<\/p>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"bottom mt-12\" data-scroll data-fade-up>\n\t\t\t\t\t\t\t\t<a href=\"https:\/\/academy.ehc.eu\/wp-content\/uploads\/2025\/01\/NTR-January-2025.pdf\" target=\"_blank\" class=\"btn with-icon\">\n\t\t\t\t\t\t\t\t\t<span>Read the EHC NTR 2025 Issue One<\/span>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/section>\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EHC je objavio prvo izdanje za 2025. godinu svog Novog pregleda lije\u010denja (NTR), periodi\u010dnog pregleda novih tretmana kod rijetkih poreme\u0107aja krvarenja.<\/p>\n","protected":false},"author":4,"featured_media":3497,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[55],"tags":[147],"class_list":["post-6062","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-hr","tag-ntr"],"acf":[],"jetpack_featured_media_url":"https:\/\/etngbd86n6b.exactdn.com\/wp-content\/uploads\/2025\/01\/NTR-Jan-2025-Blog-banner.jpg?strip=all&sharp=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/posts\/6062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/comments?post=6062"}],"version-history":[{"count":1,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/posts\/6062\/revisions"}],"predecessor-version":[{"id":6065,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/posts\/6062\/revisions\/6065"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/media\/3497"}],"wp:attachment":[{"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/media?parent=6062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/categories?post=6062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ehc.eu\/hr\/wp-json\/wp\/v2\/tags?post=6062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}